momentum. strategic lot paying earnings I’m progress good through and and investments call. this Kim, you, Welcome our a and revenue our growth off to quarter Thank everyone. of say are happy strong accelerated conference Great. to third We made afternoon, XXXX quarter,
product with and have capitalizing market accounts conditions portfolio, investment associated at around promotions and including advertising success on As activity CooperSurgical. key we and our driving initiatives, by several we CooperVision PARAGARD continue and accelerated current strong
result in revenue strategy investment growth. continued We’re confident strong this will
an which up a all-time by revenues, company. rate Non-GAAP worse gross quarter. FX $XXX and results, $X, in forecast Regarding offset earnings being tax lower incremental reported revenue margins high financial were had were year-over-year, Overall we per spending the strength our for third the we than and XX% currency headwinds, year-over-year. $X.XX of including share is million, quarter consolidated planned XX% for up
X% our record $XXX CooperVision daily at businesses, revenues up MyDay and worldwide. stronger Looking We growth a X% pro than $XXX revenue noticeable or posted of by uptick solid clariti of pro pro forma, two record up from silicone million, posted with X% quarterly million, growth CooperSurgical by XX%, or hydrogel saw our expected of forma XX% driven of growth led in up posting lenses up XX% forma. PARAGARD.
was we and against results by have dailies sphere our MyDay strong suite and Biofinity region Avaira comp all Asia-Pac detail. Americas all Moving we’re where hydrogel effect really to where The for products. halo strong on revenue results. solid gaining accounts, well very regions silicone posted X%, growth extremely Toric a our clariti quarter and and driven EMEA including the our in with going was strength of sphere, up the X%, of the up growth three products, traction. posted focused evident up full CooperVision XX%. In seeing suite Americas X%, launch MyDay been challenging posted EMEA and of solid with within is key and particular, Success by a the forma pro driven our the especially in very heavily MyDay. a
accounts, investment and of driven silicone region strategies results, very posting force success. lot hydrogel This Biofinity. dailies continued around expansion yielding expansion and Asia-Pac a by strong sales key continue us for is growth a geographic and our our fantastic
continue reasons momentum. forma. based of QX X% Avaira quarter strength to On grow for Biofinity strong products, and expect pro very on overall, was number our a a combined the So and we to
again Biofinity, help demand were will the be franchise, capacity already but especially entire have has Energys, successful the Biofinity as but adding new and will capacity even Biofinity This added constrained this coming exceeded quarter, been slightly where this expansion more product months. Regarding than supply, expected. capacity we has more in
we’ve Avaira, able Regarding we than where transitioning approval. a focus slightly, total declined the is on is to that, nice Americas, final a selling but and small sign results. the outside had regulatory for upgrade future outside Vitality finished the few good A markets, awaiting takeaway sales of generally where been now product, that’s rather growth we’re
categories, Torics pro respectively Toric, product driven and multifocal, and grew strong MyDay hydrogel we including by which is in lenses, was in X% Turning extremely received global remain silicone and markets; forma. numerous clariti Growth XX%, Multifocals well being leader growth. posted which a to and our
great product to our dailies, to market. growth. that we recently, billion, to many certain accounts continuing hydrogel topic we’re have new a topic was minutes term nice $X.X with hydrogel are regional share majority than Turning broader retailers, respect heard broader on a soft spend strength the of and CooperVision And or by discuss With drive new global of the XX% dailies. especially strong to accounts lens offerings the and silicone to has silicone buying a it’s lens the hydrogel for is as this expansion. This to that faster groups. a saw that geographic surprise $X.X growth that’s significant majority strong robust lenses long-term includes no fits accounting true I growing solidly and billion growth silicone overall within market new and overall see market, are Daily fit driving lenses, expect outpacing data, shift continued of segue the now the led roughly the which as in a to and daily contact Key for growth market, key fit me you growth these couple general of This data is trend. for sign and we continued continue want a accounts. is is chains use, a sustainable
new such seven important annuity promotional as supporting years revenue robust improve wearers platforms these support faster and key on expectations, And teams, shifting upfront As accelerated continue product on many this product look including part related is business, focused our in hydrogel this All of reflected the packaging lenses this and remembering, stay patients provide our we the been in will area operate Prime. with through which in proactively advertising our market supporting area in expanding have new and win activity. customized to activity ability Eye to strategy strong increasing and current capitalize investments silicone to cost investment and years. is their further wearers partners new enhancing with distribution this capabilities to to practitioner in been the is we fully offerings. we the revenue third past, important for remains than continue management also has and our It’s activity portfolio on account our will heightened in Fit This CooperVision sales digital conjunction will an an and and our unique conditions. we average of patients from our as tail as in our the growth that support to while We marketing Care business. our exceeding quarter, New part A such, independent and add Data. this our up, while key investing performance channel, is
guidance X% all QX Given future in to pro revenue revenue forma more confident are to raising this, growth we CooperVision’s are our growth and XX%.
This Moving healthy to quarterly of reported up office driven which pro surgical led our grew up a CooperSurgical. PARAGARD forma. X% by million, $XXX or We and was X% revenue pro products, X%. forma, by XX%
This to spent carrier NIPT. fertility as some screening the was includes by increased multi-year growing completing and accordingly. recently we’ve Outside added adding but remain our product PARAGARD, a very process Meanwhile, still but the promotional Endosee and genomics which at is and want growth activity products. office easy, products, offset have we had number business, including be. been we grew IVF a we pro and strong opportunity growth of this manipulator, strong where X% based the solutions, are and our are focus momentum moved strength several uterine Hysteroscope led surgical quickly wasn’t such a which This fertility next-generation older where full additional and and exactly buy-in products, digits. advertising with sales unexpectedly and away seeing, our transition double offers we some from focused returning confident in to high-margin devices reps. by our PARAGARD, our Regarding to softness medical in products media on of significant of investing quarter forma, was clinics, now We support within time
is X% our posted want areas, growth with product to CooperSurgical. We’re micropipets, CooperVision world In a certain growing forma about And strong catheters by PARAGARD around offer our CooperVision both strong. this very strong in hydrogel from embryo Americas genetic with nice with a which a media, X% very and growth been and for throughout strength market-leading market seen pro the several including To strength nicely, We that conclusion, has to led daily including points, really in growth, fertility pro clinics I our we leader uptick CooperSurgical continue. throughout in growing tests. global posted positions engagement our highlight including transfer summarize world, the portfolio and silicone X%. excited product a very franchise. key forma of I’m fertility portfolio, expect quarter and few the
with our look And future Given the combined maintaining we’re current to excited forward over to in both that, dynamics, momentum. the strong our I’ll call turn Brian. product businesses, market with strong portfolios about and